<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">Lopinavir is a protease inhibitor which targets the HIV virus. It was identified by 1998 and approved b the FDA by 2000. This drug prevents the formation of viral proteins by disrupting the proteolytic processing by mimicking its structure as a peptide cleaved by HIV protease. This drug along with another flu drug oseltamivir was reported to result in complete recovery after showing signs of COVID-19 related pneumonia (
 <xref rid="bb0845" ref-type="bibr">Wu et al., 2020a</xref>, 
 <xref rid="bb0850" ref-type="bibr">Wu et al., 2020b</xref>).
</p>
